| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Ayala Pharmaceuticals, Inc. (ADXS) has 0 insiders with recent SEC Form 4 filings, including 0 buys and 12 sells. ADXS is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Nov 6, 2017 | Bonstein Sara | Chief Financial Officer | Sell | 3,862 | $3.30 | $12,744.60 | -1.7% | |
| Nov 2, 2017 | Petit Robert | Chief Scientific Officer | Sell | 12,625 | $3.19 | $40,273.75 | -5.3% | |
| Nov 2, 2017 | Lombardo Anthony A | Interim CEO | Sell | 24 | $3.19 | $76.56 | - | |
| Nov 2, 2017 | Bonstein Sara | Chief Financial Officer | Sell | 12,734 | $3.19 | $40,621.46 | -5.2% | |
| Oct 11, 2017 | Adage Capital Partners Gp, L.l.c.64 | 10% Owner | Sell | 600,000 | $4.30 | $2,580,000.00 | -12.8% | |
| Sep 26, 2017 | Adage Capital Partners Gp, L.l.c.64 | 10% Owner | Sell | 1,239,323 | $4.42 | $5,474,434.74 | -7.6% | |
| Mar 31, 2017 | Petit Robert | Chief Scientific Officer | Sell | 2,454 | $8.24 | $20,220.96 | -2.0% | |
| Dec 30, 2016 | Bonstein Sara | Chief Financial Officer | Sell | 5,520 | $7.37 | $40,682.40 | -4.2% | |
| Dec 20, 2016 | McKearn Thomas J | Director | Sell | 12,316 | $8.08 | $99,513.28 | -15.0% | |
| Nov 2, 2016 | Petit Robert | Chief Scientific Officer | Sell | 2,797 | $8.32 | $23,271.04 | -2.3% |